
    
      In a multi-center pragmatic clinical trial, COVID-19 positive patients admitted to 6 United
      States medical centers were enrolled between March 10 and June 4, 2020. A machine learning
      algorithm was used to determine which patients were suitable for treatment with
      hydroxychloroquine.
    
  